Seres Therapeutics with Serious Gains – IPO Weekly Recap 6.27.2015
This past week eleven IPOs debuted, three updated terms and ten new deals were filed. The busiest calendar week thus far in 2015 for the IPO market saw a pair of company’s amass very large gains. The biggest of the bunch was Seres Therapeutics (Nasdaq: MCRB) which priced $1.00 above range, $18.00, and opened for[…]
